ARCT peer analysis
Arcturus (ARCT) against its competitors: price, today's move, 1-year return and market value side by side.
- ARCT's peers: ABUS (Arbutus Biopharma), AVIR (Atea Pharmaceuticals), BNTC (Benitec Biopharma), INO (Inovio Pharmaceuticals), NVAX (Novavax), PRQR (ProQR Therapeutics), RCKT (Rocket Pharmaceuticals), SLN (Silence Therapeutics).
ARCT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABUS Arbutus Biopharma | $3.98 | -2.21% | -6.79% | $610.11M |
| AVIR Atea Pharmaceuticals | $3.97 | 1.02% | 26.03% | $318.81M |
| BNTC Benitec Biopharma | $7.93 | -2.58% | -39.47% | $286.42M |
| INO Inovio Pharmaceuticals | $1.84 | 7.60% | 3.37% | $127.13M |
| NVAX Novavax | $7.55 | -2.20% | 19.09% | $1.25B |
| PRQR ProQR Therapeutics | $1.04 | -0.95% | -48.77% | $146.77M |
| RCKT Rocket Pharmaceuticals | $2.01 | -4.77% | -30.23% | $224.36M |
| SLN Silence Therapeutics | $19.81 | 0.00% | 208.09% | $935.70M |
| VALN Valneva | $5.37 | 0.47% | -38.33% | $503.46M |
| VIR Vir Biotechnology | $8.30 | -6.40% | 52.61% | $1.42B |
| ARCT Arcturus | $7.55 | -0.66% | 25.00% | $217.61M |